WFS1_HUMAN - dbPTM
WFS1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID WFS1_HUMAN
UniProt AC O76024
Protein Name Wolframin
Gene Name WFS1
Organism Homo sapiens (Human).
Sequence Length 890
Subcellular Localization Endoplasmic reticulum membrane
Multi-pass membrane protein.
Protein Description Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store..
Protein Sequence MDSNTAPLGPSCPQPPPAPQPQARSRLNATASLEQERSERPRAPGPQAGPGPGVRDAAAPAEPQAQHTRSRERADGTGPTKGDMEIPFEEVLERAKAGDPKAQTEVGKHYLQLAGDTDEELNSCTAVDWLVLAAKQGRREAVKLLRRCLADRRGITSENEREVRQLSSETDLERAVRKAALVMYWKLNPKKKKQVAVAELLENVGQVNEHDGGAQPGPVPKSLQKQRRMLERLVSSESKNYIALDDFVEITKKYAKGVIPSSLFLQDDEDDDELAGKSPEDLPLRLKVVKYPLHAIMEIKEYLIDMASRAGMHWLSTIIPTHHINALIFFFIVSNLTIDFFAFFIPLVIFYLSFISMVICTLKVFQDSKAWENFRTLTDLLLRFEPNLDVEQAEVNFGWNHLEPYAHFLLSVFFVIFSFPIASKDCIPCSELAVITGFFTVTSYLSLSTHAEPYTRRALATEVTAGLLSLLPSMPLNWPYLKVLGQTFITVPVGHLVVLNVSVPCLLYVYLLYLFFRMAQLRNFKGTYCYLVPYLVCFMWCELSVVILLESTGLGLLRASIGYFLFLFALPILVAGLALVGVLQFARWFTSLELTKIAVTVAVCSVPLLLRWWTKASFSVVGMVKSLTRSSMVKLILVWLTAIVLFCWFYVYRSEGMKVYNSTLTWQQYGALCGPRAWKETNMARTQILCSHLEGHRVTWTGRFKYVRVTDIDNSAESAINMLPFFIGDWMRCLYGEAYPACSPGNTSTAEEELCRLKLLAKHPCHIKKFDRYKFEITVGMPFSSGADGSRSREEDDVTKDIVLRASSEFKSVLLSLRQGSLIEFSTILEGRLGSKWPVFELKAISCLNCMAQLSPTRRHVKIEHDWRSTVHGAVKFAFDFFFFPFLSAA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDSNTAPL
-------CCCCCCCC
13.2322814378
25PhosphorylationAPQPQARSRLNATAS
CCCCCHHHHHCCCCC
44.1023403867
28N-linked_GlycosylationPQARSRLNATASLEQ
CCHHHHHCCCCCHHH
33.85-
28N-linked_GlycosylationPQARSRLNATASLEQ
CCHHHHHCCCCCHHH
33.8511181517
30PhosphorylationARSRLNATASLEQER
HHHHHCCCCCHHHHH
18.7329255136
32PhosphorylationSRLNATASLEQERSE
HHHCCCCCHHHHHHC
28.2529255136
38PhosphorylationASLEQERSERPRAPG
CCHHHHHHCCCCCCC
36.8923403867
68PhosphorylationAEPQAQHTRSRERAD
CCCCCHHCCCCCCCC
20.4723532336
70PhosphorylationPQAQHTRSRERADGT
CCCHHCCCCCCCCCC
39.3824173317
143MalonylationQGRREAVKLLRRCLA
CCHHHHHHHHHHHHH
49.1826320211
157PhosphorylationADRRGITSENEREVR
HHHCCCCCHHHHHHH
36.18-
167PhosphorylationEREVRQLSSETDLER
HHHHHHHCCHHHHHH
20.1430622161
168PhosphorylationREVRQLSSETDLERA
HHHHHHCCHHHHHHH
53.7830622161
170PhosphorylationVRQLSSETDLERAVR
HHHHCCHHHHHHHHH
48.0830622161
184PhosphorylationRKAALVMYWKLNPKK
HHHHHHHHHCCCHHH
7.6027642862
221UbiquitinationAQPGPVPKSLQKQRR
CCCCCCCHHHHHHHH
65.12-
235PhosphorylationRMLERLVSSESKNYI
HHHHHHHCCCCCCEE
32.7430266825
236PhosphorylationMLERLVSSESKNYIA
HHHHHHCCCCCCEEE
38.1127273156
238PhosphorylationERLVSSESKNYIALD
HHHHCCCCCCEEEHH
28.3130266825
241PhosphorylationVSSESKNYIALDDFV
HCCCCCCEEEHHHHH
7.4228152594
252UbiquitinationDDFVEITKKYAKGVI
HHHHHHHHHHHCCCC
49.8221906983
256UbiquitinationEITKKYAKGVIPSSL
HHHHHHHCCCCCHHH
51.0921906983
262PhosphorylationAKGVIPSSLFLQDDE
HCCCCCHHHCCCCCC
20.1324173317
277UbiquitinationDDDELAGKSPEDLPL
CCCHHCCCCHHHCCH
58.1721906983
278PhosphorylationDDELAGKSPEDLPLR
CCHHCCCCHHHCCHH
32.38-
335N-linked_GlycosylationIFFFIVSNLTIDFFA
HHHHHHCCCCHHHHH
30.24-
335N-linked_GlycosylationIFFFIVSNLTIDFFA
HHHHHHCCCCHHHHH
30.2411181517
369UbiquitinationLKVFQDSKAWENFRT
HHHHCCCHHHHHHHH
66.85-
500N-linked_GlycosylationVGHLVVLNVSVPCLL
CCCEEECCCHHHHHH
16.65-
500N-linked_GlycosylationVGHLVVLNVSVPCLL
CCCEEECCCHHHHHH
16.6511181517
630PhosphorylationMVKSLTRSSMVKLIL
HHHHCCHHHHHHHHH
19.9720068230
631PhosphorylationVKSLTRSSMVKLILV
HHHCCHHHHHHHHHH
25.0520068230
661N-linked_GlycosylationSEGMKVYNSTLTWQQ
HCCCEEECCEEEHHH
31.3511181517
661N-linked_GlycosylationSEGMKVYNSTLTWQQ
HCCCEEECCEEEHHH
31.35UniProtKB CARBOHYD
679UbiquitinationLCGPRAWKETNMART
HHCHHHHHHHCHHHH
54.3921906983
686PhosphorylationKETNMARTQILCSHL
HHHCHHHHHHHHHHH
15.4929209046
691PhosphorylationARTQILCSHLEGHRV
HHHHHHHHHHCCCEE
27.8829209046
699PhosphorylationHLEGHRVTWTGRFKY
HHCCCEEEEEEECEE
19.7729209046
701PhosphorylationEGHRVTWTGRFKYVR
CCCEEEEEEECEEEE
14.7629209046
746N-linked_GlycosylationYPACSPGNTSTAEEE
CCCCCCCCCCHHHHH
33.95UniProtKB CARBOHYD
746N-linked_GlycosylationYPACSPGNTSTAEEE
CCCCCCCCCCHHHHH
33.9511181517
762UbiquitinationCRLKLLAKHPCHIKK
HHHHHHHHCCCCCCC
48.31-
792PhosphorylationSGADGSRSREEDDVT
CCCCCCCCCCCCCCC
45.82-
799PhosphorylationSREEDDVTKDIVLRA
CCCCCCCCHHHHHHH
29.96-
800UbiquitinationREEDDVTKDIVLRAS
CCCCCCCHHHHHHHC
45.3521906983
811UbiquitinationLRASSEFKSVLLSLR
HHHCHHHHHHHHHHH
35.2921906983
821PhosphorylationLLSLRQGSLIEFSTI
HHHHHCCCEEEEEHH
20.1721406692
826PhosphorylationQGSLIEFSTILEGRL
CCCEEEEEHHHCCCC
11.1821406692
827PhosphorylationGSLIEFSTILEGRLG
CCEEEEEHHHCCCCC
34.6021406692
836UbiquitinationLEGRLGSKWPVFELK
HCCCCCCCCCCHHHH
54.4321906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
30TPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
32SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of WFS1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of WFS1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMUF1_HUMANSMURF1physical
21454619
ATF6A_HUMANATF6physical
20160352
PSA5_HUMANPSMA5physical
20160352
SYVN1_HUMANSYVN1physical
20160352

Drug and Disease Associations
Kegg Disease
H00409 Type II diabetes mellitus
H00604 Deafness, autosomal dominant
H00854 Wolfram syndrome (WFS); DIDMOAD syndrome
OMIM Disease
222300Wolfram syndrome 1 (WFS1)
600965Deafness, autosomal dominant, 6 (DFNA6)
614296Wolfram-like syndrome autosomal dominant (WFSL)
116400Cataract 41 (CTRCT41)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of WFS1_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP